Bone Health in Perimenopause and Menopause
A Guide for Women on Bone Health and Osteoporosis Prevention
At Radiant Health for Women in Boulder, Colorado, I often tell my patients this:
Hot flashes get the attention.
Sleep disruption gets the frustration.
But bone loss is the quiet change that deserves just as much focus.
For women in perimenopause and menopause, protecting bone density is one of the most important long-term health decisions you can make. And the earlier we address it, the better the outcome.
If you're a midlife woman in Boulder who values staying active — hiking, skiing, strength training, walking Pearl Street, chasing grandkids — bone health matters more than you may realize.
Why Bone Loss Accelerates During Menopause
Estrogen is not just a reproductive hormone — it’s a bone-protective hormone.
As estrogen declines during perimenopause and drops further after menopause, bone remodeling shifts. The cells that break down bone (osteoclasts) begin to outpace the cells that build bone (osteoblasts).
Research shows women can lose approximately 10% of bone density in the first 5–7 years after menopause.
This transition significantly increases risk for:
Osteopenia
Osteoporosis
Hip, spine, and wrist fractures
And here’s the key: this process often begins before your periods fully stop.
Why This Matters in an Active Community Like Boulder County
Living in Boulder County means many women prioritize movement and outdoor activity. But high activity levels do not automatically protect against hormonally driven bone loss.
In fact, I often see very fit, health-conscious women who are surprised by early osteopenia on screening.
Bone health is hormonal health.
Who Should Consider Early Bone Screening?
The standard recommendation is bone density screening at age 65. But earlier screening is often appropriate if you:
Entered menopause before age 45
Have a family history of hip fracture
Have low body weight
Have thyroid imbalance
Have used steroids long-term
Smoke or consume excess alcohol
Notice height loss
The gold standard test is a:
Dual-energy X-ray absorptiometry (DEXA scan)
This quick, low-radiation scan measures bone mineral density and helps determine fracture risk.
In my menopause practice in Boulder, we individualize timing rather than waiting for a one-size-fits-all age cutoff.
What Actually Protects Bone Density?
There is no single magic solution. Bone health is multifactorial — and highly responsive to proactive care.
1. Strength Training (Non-negotiable)
Weight-bearing and resistance training stimulate bone formation. Walking is wonderful for cardiovascular health, but it is not enough to significantly preserve bone density on its own.
That might mean:
Lifting weights at a local gym
Resistance training at home
Pilates or supervised strength sessions
Two to three sessions per week can make a measurable difference.
2. Adequate Protein Intake
Most midlife women under-eat protein, especially during weight loss efforts.
Optimizing protein supports:
Bone matrix integrity
Muscle mass
Fall prevention
Muscle and bone health are deeply interconnected.
3. Vitamin D Optimization
Vitamin D supports calcium absorption and bone mineralization. Colorado’s sunny climate helps — but it does not guarantee optimal levels year-round.
Testing is more precise than guessing.
4. Sleep & Stress Regulation
Chronic cortisol elevation accelerates bone breakdown. Untreated insomnia — extremely common in perimenopause — is not just an annoyance. It’s a metabolic and skeletal stressor.
Addressing sleep is part of protecting your bones.
5. Menopausal Hormone Therapy (formerly known as HRT)
Menopausal hormone therapy (MHT) is one of the most effective evidence-based tools for preventing bone loss during the menopausal transition.
The North American Menopause Society and multiple long-term studies show that estrogen therapy:
Reduces bone turnover
Preserves bone mineral density
Decreases fracture risk
What the Research Shows About Hormone Therapy and Bone Strength
A large review of 57 studies found that after 2 years of hormone therapy, women had significantly stronger bones compared to women not taking hormones — about 7% stronger in the lower spine, 5% stronger in the forearm, and 4% stronger in the hip.
Why Some Bones Respond Better Than Others
Your spine tends to show the biggest improvement because it contains more of the spongy inner bone tissue that responds well to estrogen. Hip bones, which are denser and more compact, still improve — just not quite as much. The good news? Most bone gains happen in the first 1-2 years, then your bones maintain that protection as long as you continue therapy.
What This Means for Fracture Risk
These bone density improvements aren't just numbers — they translate to real protection against broken bones. Studies show hormone therapy reduces fracture risk by 20-40% throughout your skeleton, including a 34% lower risk of hip fractures. What makes hormone therapy unique is that it works for all women, regardless of whether you started with strong or weaker bones.
What Happens If You Stop
Here's the important part: when you stop hormone therapy, bone loss starts up again fairly quickly. However, some protective benefit may linger for 2+ years, especially if you started treatment early in menopause.
At Radiant Health for Women, we carefully evaluate candidacy and personalize therapy rather than applying blanket recommendations.
The Bigger Picture: Longevity, Strength, & Independence
Bone health is not about fear of fractures.
It’s about:
Staying strong on the ski slopes
Maintaining independence into your 70s and 80s
Preventing frailty
Protecting quality of life
The menopausal transition is a powerful window of opportunity. Waiting until osteoporosis is diagnosed means we missed the prevention phase.
If You’re in Colorado and Wondering About Your Bone Health
If you are in perimenopause or menopause and have never discussed bone density, this is an ideal time to evaluate your risk.
At Radiant Health for Women in Boulder, Colorado, I specialize in comprehensive menopause care — including hormone evaluation, metabolic health, and long-term bone protection strategies tailored to active midlife women. Radiant Health for Women is currently treating women in Boulder, Lafayette, Longmont, Louisville, Superior, and throughout Colorado.
You deserve proactive care, not reactive treatment.
References
Cauley, J. A., Robbins, J., Chen, Z., Cummings, S. R., Jackson, R. D., LaCroix, A. Z., LeBoff, M., Lewis, C. E., McGowan, J., Neuner, J., Pettinger, M., Stefanick, M. L., Wactawski-Wende, J., & Watts, N. B. (2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative Randomized Trial. JAMA, 290(13), 1729–1738. https://doi.org/10.1001/jama.290.13.1729
Compston, J., McClung, M. R., & Leslie, W. D. (2019). Osteoporosis. The Lancet, 393(10169), 364–376. https://doi.org/10.1016/S0140-6736(18)32112-3
Crandall, C. J., Mehta, J. M., & Manson, J. E. (2023). Management of menopausal symptoms: A review. JAMA, 329(5), 405–420. https://doi.org/10.1001/jama.2022.24140
Gosset, A., Pouillès, J. M., & Trémollieres, F. (2021). Menopausal hormone therapy for the management of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism, 35(6), 101551. https://doi.org/10.1016/j.beem.2021.101551
Lobo, R. A., & Gompel, A. (2022). Management of menopause: A view towards prevention. The Lancet Diabetes & Endocrinology, 10(6), 457–470. https://doi.org/10.1016/S2213-8587(21)00269-2
North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028
U.S. Preventive Services Task Force. (2025). Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. JAMA, 333(5), 498–509. https://doi.org/10.1001/jama.2024.27154
Walker, M. D., & Shane, E. (2023). Postmenopausal osteoporosis. New England Journal of Medicine, 389(21), 1979–1991. https://doi.org/10.1056/NEJMcp2307353
Wells, G., Tugwell, P., Shea, B., Guyatt, G., Peterson, J., Zytaruk, N., Robinson, V., Henry, D., O'Connell, D., & Cranney, A. (2002). Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocrine Reviews, 23(4), 529–539. https://doi.org/10.1210/er.2001-5002